- Patent Litigation
- Pharmaceutical Patents
- Biotechnology Patents
- Nanotechnology Patents
- Patent Opposition
- Intellectual Property
- Industrial Property
- European Patents
- International Patents
- Chemical Patents
- Patent Prosecution
- Design Patents
|Contact Info||Telephone: +39 06695441|
Fax: Fax: +39 0669544810/20
|Education||University of Milan (Pharmaceutical Chemistry and Technology)|
|Admitted||Italian Patent Attorney; Italian and European Trademark Attorney; European Design Attorney|
|Memberships ||Italian Industrial Property Consultants Institute; Institute of Professional Representatives before the European Patent Office; AIPPI; FICPI (Biotechnology Committee); Industrial Property of the Court of Rome (enrolled with the Register of Court-Appointed Experts).|
|Languages||English, French, German and Spanish|
Main activity providing technical counsel in patent litigation in the pharmaceutical field. Represents big pharma originator companies in infringement and nullity proceedings before Italian tribunals and courts, often working on several parallel national and transborder proceedings at once as well as maintaining strong coordination with foreign law firms.
Member of firm's Nano Bio team, involved in drafting, filing and prosecuting patent applications concerning new technologies in the nanotechnology platform. Performs freedom to operate and portfolio analyses in view of acquisitions and mergers of biotech and pharma companies.
Clients include primary multinational pharma companies, Italian and foreign public research institutions, Italian and foreign SMEs developing classic and high-tech medicaments in the fields of biotechnology and nanotechnology.
Joined SIB 2001 after spending over 20 years with the European Patent Office in Munich, first as a biotechnology examiner and later as a member of the board of appeal competent for pharmaceuticals. Acted as rapporteur or chairman in more than 100 decisions on key points of law such as interpretation of a medicament's second therapeutic application, definition of and interaction between medical and non-medical treatments, limit of a reach-through claim, meaning of a functional claim, applicability of non-supported disclaimers, anticipating effect of speculative prior art, and others.
Documents by this lawyer on Martindale.com
A Comparative Look at Bowman vs. Monsanto in the European Context
Claudio Germinario, July 10, 2013, previously published by Bloomberg BNA World Intellectual Property Report
on Summer 2013
On May 13, 2013, the US Supreme Court upheld the decisions of the Court of Appeals for the Federal Circuit and of the District Court for the Southern District of Indiana, holding in favour of Monsanto in the Bowman v. Monsanto dispute.
|Profile Visibility |
|#25 in weekly profile views out of 2,651 lawyers in Rome, Italy|
|#47,347 in weekly profile views out of 1,505,612 total lawyers Overall|